Evolutionary Genomics, Inc. (FNAM)

0.4500 0.0000 (0.00%) At close: 03:26PM EDT

Evolutionary Genomics, Inc.

4220 Morning Star Drive
Castle Rock, CO 80108
United States
720 900 8666
https://www.evolgen.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 2

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Steve B. Warnecke	Chairman, CEO, President & CFO	140.1k	N/A	1957
Dr. Walter Messier Ph.D.	Founder, CTO, Treasurer & Secretary	150k	N/A	1956
Ms. Virginia Orndorff	Founder & Director	10k	N/A	1951

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. The company is based in Castle Rock, Colorado.

Corporate Governance

Evolutionary Genomics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.